These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 24125629)

  • 1. Three cases of sporadic medullary thyroid carcinoma in progression treated with sunitinib.
    Currás Freixes M; Díaz Pérez JÁ; Casado Herráez A; Ochagavía Cámara S
    Endocrinol Nutr; 2014 Jan; 61(1):62-3. PubMed ID: 24125629
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to sunitinib in medullary thyroid cancer.
    Kelleher FC; McDermott R
    Ann Intern Med; 2008 Apr; 148(7):567. PubMed ID: 18378960
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of sunitinib in advanced medullary thyroid carcinoma: intermediate results of phase II THYSU.
    Ravaud A; de la Fouchardière C; Asselineau J; Delord JP; Do Cao C; Niccoli P; Rodien P; Klein M; Catargi B
    Oncologist; 2010; 15(2):212-3; author reply 214. PubMed ID: 20189981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harvesting the low-hanging fruit: kinase inhibitors for therapy of advanced medullary and nonmedullary thyroid cancer.
    Fagin JA; Tuttle RM; Pfister DG
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2621-4. PubMed ID: 20525911
    [No Abstract]   [Full Text] [Related]  

  • 5. Approach to lymph node metastases in sporadic medullary thyroid carcinoma An istitutional experience.
    Polistena A; Monacelli M; Lucchini R; Triola R; Conti C; Avenia S; Barillaro I; Sanguinetti A; Avenia N
    Ann Ital Chir; 2015; 86():390-5. PubMed ID: 26567553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant treatment of unresectable medullary thyroid cancer with sunitinib.
    Cleary JM; Sadow PM; Randolph GW; Palmer EL; Lynch TP; Nikiforov YE; Wirth LJ
    J Clin Oncol; 2010 Aug; 28(23):e390-2. PubMed ID: 20567012
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of advanced medullary thyroid carcinoma successfully treated with sunitinib.
    Bugalho MJ; Domingues R; Borges A
    Oncologist; 2009 Nov; 14(11):1083-7. PubMed ID: 19887470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic cooperation between sunitinib and cisplatin promotes apoptotic cell death in human medullary thyroid cancer.
    Lopergolo A; Nicolini V; Favini E; Dal Bo L; Tortoreto M; Cominetti D; Folini M; Perego P; Castiglioni V; Scanziani E; Borrello MG; Zaffaroni N; Cassinelli G; Lanzi C
    J Clin Endocrinol Metab; 2014 Feb; 99(2):498-509. PubMed ID: 24276455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current approaches to medullary thyroid carcinoma, sporadic and familial.
    Fialkowski EA; Moley JF
    J Surg Oncol; 2006 Dec; 94(8):737-47. PubMed ID: 17131404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sunitinib for the treatment of thyroid cancer.
    Gómez-Sáez JM
    Expert Opin Investig Drugs; 2016 Nov; 25(11):1345-1352. PubMed ID: 27677828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagic activation potentiates the antiproliferative effects of tyrosine kinase inhibitors in medullary thyroid cancer.
    Lin CI; Whang EE; Lorch JH; Ruan DT
    Surgery; 2012 Dec; 152(6):1142-9. PubMed ID: 23158184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter phase II study of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullary thyroid carcinomas: mature data from the THYSU study.
    Ravaud A; de la Fouchardière C; Caron P; Doussau A; Do Cao C; Asselineau J; Rodien P; Pouessel D; Nicolli-Sire P; Klein M; Bournaud-Salinas C; Wemeau JL; Gimbert A; Picat MQ; Pedenon D; Digue L; Daste A; Catargi B; Delord JP
    Eur J Cancer; 2017 May; 76():110-117. PubMed ID: 28301826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematologic toxicity in patients treated with sunitinib for advanced thyroid cancer.
    Gkountouvas A; Kostoglou-Athanassiou I; Veniou E; Repousis P; Ziras N; Kaldrimidis P
    Thyroid; 2010 Jun; 20(6):597-600. PubMed ID: 20553195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial remission of metastatic papillary thyroid carcinoma with sunitinib. Report of a case and review of the literature.
    Kaldrymides P; Kostoglou-Athanassiou I; Gkountouvas A; Veniou E; Ziras N
    Endocrine; 2010 Feb; 37(1):6-10. PubMed ID: 20963554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging role of sunitinib in the treatment of advanced epithelial thyroid cancer: our experience and review of literature.
    Pasqualetti G; Ricci S; Dardano A; Ferdeghini M; Del Tacca M; Monzani F
    Mini Rev Med Chem; 2011 Aug; 11(9):746-52. PubMed ID: 21707530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapeutic concepts and long-term outcome in thyroid gland carcinoma].
    Linder R; Fuhrmann J; Hammerschmidt D
    Zentralbl Chir; 1996; 121(6):459-64. PubMed ID: 8767331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerodigestive fistula formation as a rare side effect of antiangiogenic tyrosine kinase inhibitor therapy for thyroid cancer.
    Blevins DP; Dadu R; Hu M; Baik C; Balachandran D; Ross W; Gunn B; Cabanillas ME
    Thyroid; 2014 May; 24(5):918-22. PubMed ID: 24635127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed follicular and parafollicular thyroid carcinoma.
    Vitri P; Galimberti A; De Pasquale L; Vago L; Boldorini R; Bastagli A
    J Exp Clin Cancer Res; 1999 Dec; 18(4):567-9. PubMed ID: 10746987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d'Etude des Tumeurs a Calcitonine (GETC).
    Schlumberger M; Abdelmoumene N; Delisle MJ; Couette JE
    Br J Cancer; 1995 Feb; 71(2):363-5. PubMed ID: 7530987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with tyrosine kinase inhibitors for patients with differentiated thyroid cancer: the M. D. Anderson experience.
    Cabanillas ME; Waguespack SG; Bronstein Y; Williams MD; Feng L; Hernandez M; Lopez A; Sherman SI; Busaidy NL
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2588-95. PubMed ID: 20392874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.